Home » Stocks » PETQ

PetIQ, Inc. (PETQ)

Stock Price: $37.08 USD 2.21 (6.34%)
Updated Jan 27, 2021 1:38 PM EST - Market open
Market Cap 987.16M
Revenue (ttm) 770.18M
Net Income (ttm) -78.04M
Shares Out 24.94M
EPS (ttm) -3.24
PE Ratio n/a
Forward PE 24.04
Dividend n/a
Dividend Yield n/a
Trading Day January 27
Last Price $37.08
Previous Close $34.87
Change ($) 2.21
Change (%) 6.34%
Day's Open 34.34
Day's Range 34.10 - 37.75
Day's Volume 587,622
52-Week Range 16.59 - 38.45

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
InvestorPlace - 1 month ago

Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on...

Other stocks mentioned: CHD, CHWY, FRPT, IDXX, LMND, PETS, ZTS
GlobeNewsWire - 2 months ago

EAGLE, Idaho, Nov. 10, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will parti...

Seeking Alpha - 2 months ago

PetIQ, Inc. (PETQ) CEO Cord Christensen on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

PetIQ (PETQ) delivered earnings and revenue surprises of -168.75% and -2.89%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 2 months ago

EAGLE, Idaho, Nov. 05, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the t...

Zacks Investment Research - 2 months ago

PetIQ (PETQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research - 2 months ago

PetIQ (PETQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 3 months ago

EAGLE, Idaho, Oct. 22, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for...

GlobeNewsWire - 4 months ago

Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter Remains On-track for 95% of Services Segment to be Open by the End of the Third Quarter

Investors Business Daily - 5 months ago

PetIQ shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Stock Upgrades: PetIQ Shows Rising Relative Strength appeared first on Investor's Busines...

Seeking Alpha - 5 months ago

PetIQ's (PETQ) CEO Cord Christensen on Q2 2020 Results - Earnings Call Transcript

The Motley Fool - 5 months ago

The company achieved record revenue in the second quarter, but is guiding for declines.

GlobeNewsWire - 5 months ago

Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing Accretive, Strategic Transaction Adds High-margin Sales and Enhances Product Manufacturing

Zacks Investment Research - 5 months ago

PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 6 months ago

EAGLE, Idaho, July 23, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results f...

GlobeNewsWire - 6 months ago

Expects to Complete Accretive, Strategic Transaction on July 31, 2020

GlobeNewsWire - 7 months ago

EAGLE, Idaho, June 16, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that management will par...

Zacks Investment Research - 8 months ago

PetIQ (PETQ) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

GlobeNewsWire - 8 months ago

Proceeds to be Used to Fund Capstar Acquisition Capped Call to Increase Effective Conversion Price to $41.51 (75% Effective Conversion Premium)

GlobeNewsWire - 8 months ago

EAGLE, Idaho, May 14, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc.  (“PetIQ”) (NasdaqGS: PETQ) today announced its intention to offer, subject to market and other conditions, $125,000,000 aggregate ...

GlobeNewsWire - 8 months ago

EAGLE, Idaho, May 12, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the launch of its telehea...

Seeking Alpha - 8 months ago

PetIQ, Inc. (PETQ) CEO Cord Christensen on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

PETQ vs. BSX: Which Stock Is the Better Value Option?

Other stocks mentioned: BSX
Zacks Investment Research - 8 months ago

PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 9 months ago

Though price-to-earnings and price-to-sales are the first choices, P/B ratio is also a convenient tool for identifying valuable stocks.

Other stocks mentioned: ACCO, ALXN, BCOR, REZI, SEM
Zacks Investment Research - 9 months ago

PETQ vs. MDT: Which Stock Is the Better Value Option?

Other stocks mentioned: MDT
Zacks Investment Research - 9 months ago

PetIQ (PETQ) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well

The Motley Fool - 10 months ago

Spot and Fluffy are living the good life -- invest so you can too.

Other stocks mentioned: FRPT, ZTS
GlobeNewsWire - 10 months ago

EAGLE, Idaho, March 20, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that out of an abundanc...

Seeking Alpha - 10 months ago

PetIQ, Inc. (PETQ) CEO Cord Christensen on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

PetIQ (PETQ) delivered earnings and revenue surprises of -100.00% and 14.49%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Motley Fool - 11 months ago

Redfin, PetIQ, and Beyond Meat all have upcoming catalysts to propel their shares higher.

Other stocks mentioned: BYND, RDFN
GlobeNewsWire - 11 months ago

EAGLE, Idaho, Feb. 03, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of Laure...

GlobeNewsWire - 1 year ago

Celebrated 20 Wellness Center Openings in December Opened 80 Locations Across 22 States in 2019 at 5 Host Partner Locations Reaffirms 2019 Guidance Presentation at the ICR Conference Today ...

GlobeNewsWire - 1 year ago

Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Opportunity and Further Bolsters Manufacturing Accretive, Strategic Bolt-on Acquisition Provides High-margin Revenue Oppor...

InvestorPlace - 1 year ago

Small-cap stocks have lagged the market of late but these 10 stocks to buy should be doing plenty of catching up.

Other stocks mentioned: BCC, CNNE, CNTY, HEAR, KLIC, OPRA, PRGS, SAIL, TVTY
GlobeNewsWire - 1 year ago

Celebrated 34 Wellness Center Openings in November Opened 60 Locations Year-to-Date in 22 States On-Track to Add 80 New Wellness Centers in 2019

Seeking Alpha - 1 year ago

PetIQ, Inc. (PETQ) CEO Cord Christensen on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

PETQ vs. BSX: Which Stock Is the Better Value Option?

Other stocks mentioned: BSX
Zacks Investment Research - 1 year ago

Profitability analysis is considered one of the best possible ways to assess the prospects of a company.

Other stocks mentioned: COLM, FNKO, KLAC, MTRX
Benzinga - 1 year ago

Animal wellness company PetIQ Inc (NASDAQ: PETQ) handily beat expectations in its second-quarter report Thursday, mostly due to pet owners spending more money on their beloved animals.

CNBC Television - 1 year ago

PetIQ CEO talks strategic partnership with Chewy

PetIQ CEO Cord Christensen tells Jim Cramer companies partnership with Chewy helped drive earnings this quarter.

CNBC - 1 year ago

"Our partnerships with retailers has allowed us to access a population of pets and bring our mission forward of being advocates for those pet-parents," PetIQ CEO Cord Christensen tells Jim Cra...

Seeking Alpha - 1 year ago

PetIQ's (PETQ) CEO Cord Christensen on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

PetIQ (PETQ) delivered earnings and revenue surprises of 150.00% and 13.82%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Investopedia - 1 year ago

In 2019, U.S. pet owners are expected to spend more than $75 billion dollars on their animals.

Other stocks mentioned: PAWZ, ZTS
CNBC Television - 1 year ago

Jim Cramer shuffles his 'Humanization of Pets ETF' — 'It's paid off in 2019'

"The humanization of pets has been a fabulous secular growth story — one that's really paid off in 2019," Cramer says.

Other stocks mentioned: CENT, CHWY, CVET, ELAN

About PETQ

PetIQ operates as a pet medication and wellness company. It operates through two segments, Products and Services. The company offers prescription pet medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; and over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars. It also provides health and wellness products that include dental trea... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Jul 21, 2017
CEO
McCord Christensen
Employees
1,866
Stock Exchange
NASDAQ
Ticker Symbol
PETQ
Full Company Profile

Financial Performance

In 2019, PetIQ, Inc.'s revenue was $709.43 million, an increase of 34.21% compared to the previous year's $528.61 million. Losses were -$11.45 million, 1,364.6% more than in 2018.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for PetIQ, Inc. stock is "Strong Buy." The 12-month stock price forecast is 41.60, which is an increase of 12.19% from the latest price.

Price Target
$41.60
(12.19% upside)
Analyst Consensus: Strong Buy